PREVALENSI EFEK SAMPING GEJALA GASTROINTESTINAL PADA PASIEN DM TIPE 2 DALAM TERAPI METFORMIN DAN FAKTOR-FAKTOR YANG MEMPENGARUHI DI PUSKESMAS KECAMATAN PASAR REBO TAHUN 2020
Diabetes mellitus (DM) is a group of metabolic disorders indicated by hyperglycemia, which is caused by defects in insulin secretion, insulin action, or both. Metformin is first-line treatment as monotherapy if the patient has no contraindications to metformin. Unfortunately, metformin frequently ca...
Saved in:
Main Author: | Laily Afika Ayu, (Author) |
---|---|
Format: | Book |
Published: |
2021-07-03.
|
Subjects: | |
Online Access: | Link Metadata |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
by: Michael Ashamalla, et al.
Published: (2018) -
Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis
by: Gil Hevroni, et al.
Published: (2020) -
FAKTOR-FAKTOR YANG BERHUBUNGAN DENGAN KEJADIAN PENYAKIT JANTUNG KORONER PADA PASIEN DI RSUD PASAR REBO TAHUN 2020
by: Aisyah,
Published: (2021) -
ANALISIS FAKTOR RISIKO DENGAN KEJADIAN ISPA ANAK DI PUSKESMAS KECAMATAN PASAR REBO SAAT 6 BULAN PERTAMA PANDEMI COVID - 19
by: Febyola Nur Fitriyani,
Published: (2021) -
PERBEDAAN EFEKTIVITAS KOMBINASI METFORMIN DAN SULFONILUREA DENGAN KOMBINASI METFORMIN DAN PENGHAMBAT DPP-IV DALAM MENGONTROL HbA1c PASIEN DM TIPE 2
by: Camelia Fasya Zhafira Arethusa,
Published: (2021)